565 related articles for article (PubMed ID: 30174259)
41. External validation of the GETTEC algorithm for elective neck dissection in patients candidates for salvage total laryngectomy.
Pujol A; León X; Holgado A; Valero C; Kolanczak K; Quer M; Virós D
Oral Oncol; 2024 Feb; 149():106686. PubMed ID: 38218021
[TBL] [Abstract][Full Text] [Related]
42. Management of the irradiated N0-neck during salvage pharyngo-laryngeal surgery.
Mazerolle P; Gorphe P; Vairel B; Dupret-Bories A; Temam S; Chaltiel L; Vergez S
Eur J Surg Oncol; 2020 Jun; 46(6):1059-1065. PubMed ID: 31952930
[TBL] [Abstract][Full Text] [Related]
43. Neck dissection in squamous cell carcinoma of the larynx: indication of elective contralateral neck dissection.
Amar A; Chedid HM; Franzi SA; Rapoport A
Braz J Otorhinolaryngol; 2012 Apr; 78(2):7-10. PubMed ID: 22499363
[TBL] [Abstract][Full Text] [Related]
44. [A clinical and pathological study on cervical lymph node metastasis in the clinical N0 patient with laryngeal carcinoma].
Jia S; Sun X; Zhang N
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Jun; 34(3):170-2. PubMed ID: 12764811
[TBL] [Abstract][Full Text] [Related]
45. Prognosis of recurrent laryngeal carcinoma after laryngectomy.
Yuen AP; Ho CM; Wei WI; Lam LK
Head Neck; 1995; 17(6):526-30. PubMed ID: 8847211
[TBL] [Abstract][Full Text] [Related]
46. The role of elective neck dissection for cT4aN0 glottic squamous cell carcinoma.
Tsushima N; Hayashi R; Shinozaki T; Tomioka T; Okano W; Ikeda M
Jpn J Clin Oncol; 2019 Jun; 49(6):525-528. PubMed ID: 30839065
[TBL] [Abstract][Full Text] [Related]
47. [Topographical and clinico-oncologic analysis of locoregional recurrence after transoral laser surgery for laryngeal cancer].
Eckel HE
Laryngorhinootologie; 1993 Aug; 72(8):406-11. PubMed ID: 8397594
[TBL] [Abstract][Full Text] [Related]
48. Is routine neck dissection warranted at salvage laryngectomy?
Sharma S; Chaukar DA; Bal M; D'Cruz AK
J Laryngol Otol; 2021 Sep; 135(9):785-790. PubMed ID: 34238396
[TBL] [Abstract][Full Text] [Related]
49. [Cervical lymph node metastasis and recurrence in supraglottic carcinoma after operation].
Pan Z; Cao Z; Liu B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):108-10. PubMed ID: 12764862
[TBL] [Abstract][Full Text] [Related]
50. The distribution of lymph node metastases in supraglottic squamous cell carcinoma: therapeutic implications.
Redaelli de Zinis LO; Nicolai P; Tomenzoli D; Ghizzardi D; Trimarchi M; Cappiello J; Peretti G; Antonelli AR
Head Neck; 2002 Oct; 24(10):913-20. PubMed ID: 12369069
[TBL] [Abstract][Full Text] [Related]
51. [The clinical analysis of cervical lymph node metastases from squamous cell carcinoma of the larynx and hypopharynx treated with total laryngectomy].
Wang K; Wang W; Zhu J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Dec; 17(12):711-3. PubMed ID: 15017712
[TBL] [Abstract][Full Text] [Related]
52. Critical appraisal of watchful waiting policy in the management of N0 neck of advanced laryngeal carcinoma.
Yuen AP; Wei WI; Wong SH
Arch Otolaryngol Head Neck Surg; 1996 Jul; 122(7):742-5. PubMed ID: 8663947
[TBL] [Abstract][Full Text] [Related]
53. Lymph node density as an independent predictor of cancer-specific mortality in patients with lymph node-positive laryngeal squamous cell carcinoma after laryngectomy.
Ryu IS; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
Head Neck; 2015 Sep; 37(9):1319-25. PubMed ID: 24828891
[TBL] [Abstract][Full Text] [Related]
54. [Parastomal tumors after laryngectomy: etiology and therapy].
Metternich FU; Brusis T
Laryngorhinootologie; 1997 Feb; 76(2):88-95. PubMed ID: 9172635
[TBL] [Abstract][Full Text] [Related]
55. Occult lymph node metastasis in laryngeal squamous cell carcinoma: therapeutic and prognostic impact.
Mnejja M; Hammami B; Bougacha L; Chakroun A; Charfeddine I; Khabir A; Boudaoura T; Ghorbel A
Eur Ann Otorhinolaryngol Head Neck Dis; 2010 Nov; 127(5):173-6. PubMed ID: 21106463
[TBL] [Abstract][Full Text] [Related]
56. [Postoperative radiotherapy in N0 laryngeal cancer].
Maillard S; Jovenin N; Cauchois A; Froissart D; Merol JC; Chays A; Nguyen TD
Cancer Radiother; 2005 Sep; 9(5):285-92. PubMed ID: 16168697
[TBL] [Abstract][Full Text] [Related]
57. Molecular assessment of neck dissections supports preserving level IIB lymph nodes in selective neck dissection for laryngeal squamous cell carcinoma with a clinically negative neck.
Elsheikh MN; Mahfouz ME; Salim EI; Elsheikh EA
ORL J Otorhinolaryngol Relat Spec; 2006; 68(3):177-84. PubMed ID: 16465073
[TBL] [Abstract][Full Text] [Related]
58. [Selection of surgical modalities for T3 glottic carcinoma].
Wen SX; Wang BQ; Liu T; Huangfu H; Zhang HL; Zhang CM; Gao W; Feng Y
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):860-3. PubMed ID: 22335954
[TBL] [Abstract][Full Text] [Related]
59. Pattern of cervical lymph node metastasis in medial wall pyriform sinus carcinoma.
Chung EJ; Lee SH; Baek SH; Park IS; Cho SJ; Rho YS
Laryngoscope; 2014 Apr; 124(4):882-7. PubMed ID: 23832757
[TBL] [Abstract][Full Text] [Related]
60. Selective neck dissection (IIA, III): a rational replacement for complete functional neck dissection in patients with N0 supraglottic and glottic squamous carcinoma.
Ferlito A; Silver CE; Rinaldo A
Laryngoscope; 2008 Apr; 118(4):676-9. PubMed ID: 18182969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
